Quidel | QDEL - Operating Profit



Quidel reported $-1800000 in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Abbott USD 2.07B 415M Jun/2025
Agilent USD 360M 60M Jul/2025
Avanos Medical USD -53660000 63.96M Jun/2025
Becton, Dickinson and Co. USD 979M 433M Jun/2025
Bruker USD 11.9M 19.9M Jun/2025
Charles River Laboratories USD 132.33M 57.66M Jun/2025
Danaher USD 760M 523M Jun/2025
Exact Sciences USD -2148000 93.86M Jun/2025
Haemonetics USD 70.84M 20.14M Jun/2025
Hologic USD 260.9M 267.9M Jun/2025
Illumina USD 214M 83M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
Merit Medical Systems USD 47.02M 5.99M Jun/2025
Mettler Toledo International USD 265.71M 63.77M Jun/2025
Myriad Genetics USD -29000000 10M Mar/2025
Neogen USD -13254000 18.67M May/2025
Quidel USD -1800000 50.5M Jun/2025
Revvity USD 90.76M 18.53M Jun/2025
STAAR Surgical USD -24716000 10.02M Jun/2025
Thermo Fisher Scientific USD 1.92B 200M Jun/2025
Waters USD 188.21M 36.47M Jun/2025